Abstract

During the 11th Breast-Gynecological and Immunooncology International Cancer Conference (BGICC), which was held on 17 and 18 January 2019, in Cairo, Egypt, around 100 international, regional and national experts from every continent presented the latest updates in breast cancer, gynaecological cancers and immunotherapy in oncology. Through this report, we highlight the important data and consensus issues that were discussed during the conference.

Highlights

  • The Breast-Gynecological and Immunooncology International Cancer Conference (BGICC) annual meeting, which was held on 17 and 18 January 2019 in Cairo, Egypt, was a global, multidisciplinary conference with representatives from 80 nations and every continent

  • Attendance at the 11th BGICC was increased by 15% and abstract submission was increased by 30% this year

  • BGICC has partnered with leading societies of oncology and well recognised cancer foundations worldwide, such as the American Society of Clinical Oncology, the European School of Oncology (ESO), the European Society of Surgical Oncology, the Society of Geriatric Oncology (SIOG), the African Palliative Care Association, the European Society of Radiotherapy, the European Society of Gynaecology, the European Society of Oncology Imaging, the Russian Association of Oncomamoplastic (RAOM), the Faculty of Medicine at Ain Shams Research Institute, the Breast Gynecological International Cancer Society (BGICS), Breast Surgery International, the Society for Immunotherapy of Cancer, the Biobank and Cohort Building Network and Nature research

Read more

Summary

Introduction

The Breast-Gynecological and Immunooncology International Cancer Conference (BGICC) annual meeting, which was held on 17 and 18 January 2019 in Cairo, Egypt, was a global, multidisciplinary conference with representatives from 80 nations and every continent. BGICC has partnered with leading societies of oncology and well recognised cancer foundations worldwide, such as the American Society of Clinical Oncology, the European School of Oncology (ESO), the European Society of Surgical Oncology, the Society of Geriatric Oncology (SIOG), the African Palliative Care Association, the European Society of Radiotherapy, the European Society of Gynaecology, the European Society of Oncology Imaging, the Russian Association of Oncomamoplastic (RAOM), the Faculty of Medicine at Ain Shams Research Institute, the Breast Gynecological International Cancer Society (BGICS), Breast Surgery International, the Society for Immunotherapy of Cancer, the Biobank and Cohort Building Network and Nature research. Temic therapy, nursing, clinical pharmacy, palliative care, scientific research, as well as genetics, molecular biology of breast cancer and industry-sponsored symposia. In view of personalised medicine, there was an intensive course about Molecular Biology followed by a post-conference three-day ‘hands-on’ workshop in collaboration with Thermofisher and Fudan University concentrating on first Generation Sequencing

Advances in endocrine therapy
Adjuvant treatment
Fertility issues in premenopausal breast cancer patients
Neoadjuvant treatment in breast cancer
Management of advanced cervical cancer
Management of breast cancer in the elderly
Management of axilla in breast cancer
Findings
Summary
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.